Target early discovery Analiza specializes in physicochemical and ADME analyses for early drug discovery, presenting opportunities to upsell expanded solubility, LogD, and pKa profiling services to small and large pharma and biotech clients seeking faster, cost-effective exploratory data.

Automation and throughput Leverage Analiza's history of automated, miniaturized shake flask LogD systems to position scalable, high-throughput measurements for discovery programs with tight timelines and sample constraints.

Cost-conscious value With a track record of affordable analytical services and substantial cumulative measurements, target budget-restrained teams prioritizing cost-per-data-point without sacrificing quality.

Track record credibility Analiza has decades of experience and quantified outputs (hundreds of thousands of solubility and LogD measurements), which can be used to build trust with procurement and R&D leaders evaluating external physicochemical partners.

Expansion opportunities Potential cross-sell to co-locate or expand external ADME profiling capabilities, including in-house physchem, enabling broader collaboration with mid to large pharma and biotech players seeking end-to-end services.